Allergy Therapeutics shares jump as hails grass allergy jab data

Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry.

The Sussex-based biotechnology...

Related Keywords

Hugh Cameron ,Manuel Llobet ,Alliance News Ltd ,Allergy Therapeutics ,Alliance News ,Executive Officer Manuel Llobet ,All Rights ,Markets ,